Canada markets open in 1 hour 44 minutes

Evelo Biosciences, Inc. (EVLO)

OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
Add to watchlist
0.06000.0000 (0.00%)
At close: 12:18PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
81,351
78,554
83,643
69,616
63,128
Selling General and Administrative
33,587
29,912
31,753
22,270
23,229
Total Operating Expenses
114,938
108,466
115,396
91,886
86,357
Operating Income or Loss
-114,938
-108,466
-115,396
-91,886
-86,357
Interest Expense
3,845
4,672
3,612
2,109
-
Total Other Income/Expenses Net
-372
-459
-2,740
738
26
Income Before Tax
-119,155
-113,597
-121,748
-93,257
-85,282
Income Tax Expense
483
930
428
409
190
Income from Continuing Operations
-119,638
-114,527
-122,176
-93,666
-85,472
Net Income
-119,638
-114,527
-122,176
-93,666
-85,472
Net Income available to common shareholders
-119,638
-114,527
-122,176
-93,666
-85,472
Basic EPS
-15.64
-26.20
-46.20
-47.40
-53.40
Diluted EPS
-15.64
-26.20
-46.20
-47.40
-53.40
Basic Average Shares
4,956
4,358
2,646
1,974
1,602
Diluted Average Shares
4,956
4,358
2,646
1,974
1,602